近日，一家致力于为生物技术领域建立大型语言模型的初创公司——Bioptimus，成功筹集了3500万美元的种子轮资金。这家公司在创立仅几个月后，便吸引了众多投资者的关注，并获得了丰厚的资金支持。
本轮融资由法国知名的生命科学风险投资公司Sofinnova Partners和公共银行Bpifrance Large Ventures共同领投。此外，法国风险投资公司Frst、Cathay Innovation以及美国投资者Headline、Owkin和亿万富翁企业家Xavier Niel等也参与了本轮融资。
Bioptimus公司旨在利用人工智能技术，为生物技术领域提供一个强大的语言模型。该模型将有助于推动生物科技行业的研究与开发，提高相关领域的创新能力。据悉，该公司计划将筹集到的资金用于进一步研发和优化其语言模型，以满足生物科技领域对人工智能技术的日益增长需求。
作为一家具有创新精神的初创公司，Bioptimus的成功融资充分展示了其在生物技术领域的前景和潜力。随着人工智能技术的不断发展，Bioptimus有望为生物科技行业带来更多的创新成果，助力该领域实现更高质量的发展。
此次融资将有助于Bioptimus扩大团队规模，进一步提升公司在生物技术领域的竞争力。同时，该公司还计划加强与国际合作伙伴的合作，共同推动全球生物科技行业的发展。
总之，Bioptimus完成3500万美元种子轮融资，标志着该公司在生物技术领域的大型语言模型建设取得了重要进展。在未来的发展中，Bioptimus有望为生物科技行业提供更多创新解决方案，助力全球生物科技领域的繁荣发展。
英语如下：
**Headline:** “Bioptimus Secures $35 Million in Seed Funding to Lead Innovation in Biotechnology Language Models”
**Keywords:** Bioptimus, Bioscience, Seed Round Funding
**News Content:**
## Bioptimus Closes $35 Million Seed Round, Boosting Construction of Large-scale Biotechnology Language Models
Recently, Bioptimus, a startup dedicated to establishing large-scale language models in the biotechnology sector, has successfully raised $35 million in seed funding. Just months after its establishment, the company has drawn the attention of numerous investors and received substantial financial support.
This round of financing was jointly led by Sofinnova Partners, a renowned French life science venture capital firm, and Bpifrance Large Ventures, a public bank. In addition, French venture capital firm Frst, Cathay Innovation, and American investors Headline, Owkin, and billionaire entrepreneur Xavier Niel also participated in this round of financing.
Bioptimus aims to leverage artificial intelligence technology to provide a powerful language model for the biotechnology sector. This model is expected to facilitate research and development in the biotech industry and enhance the innovative capabilities of related fields. It is learned that the company plans to use the funds raised to further develop and optimize its language model, in response to the growing demand for artificial intelligence technology in biotechnology.
As an innovative startup, the successful financing of Bioptimus fully demonstrates its prospects and potential in the biotechnology sector. With the continuous development of artificial intelligence technology, Bioptimus is expected to bring more innovative achievements to the biotech industry, helping it achieve higher-quality development.
This round of financing will help Bioptimus expand its team and further enhance its competitiveness in the biotechnology sector. At the same time, the company also plans to strengthen cooperation with international partners to jointly promote the development of the global biotechnology industry.
In summary, the completion of the $35 million seed round by Bioptimus marks significant progress in the construction of large-scale language models in the biotechnology sector. In the future development, Bioptimus is expected to provide more innovative solutions for the biotechnology industry and contribute to the prosperity of the global biotech sector.
【来源】https://sifted.eu/articles/bioptimus-owkin-35m-seed
Views: 5